Expanded treatment advice, and restored links to full advice results from email.

Expanded treatment advice, and restored links to full advice results from email.

Bug fixes and expanded advice and therapy reference content.

This app has been updated with additional advice scenarios for HFpEF patients as well as some formatting and content corrections.

This app has been updated in accordance with the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction, and the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction. This update also expands the scope of the app to include clinical guidance for heart failure patients with preserved ejection fraction.

Bug fix

Bug Fix

New content from the Standards for Adult Immunization Practice has been incorporated into the TreatHF app.

•	New content from the 2021 Update to the 2017 ECDP for Optimization of Heart Failure Treatment, including information regarding use of angiotensin receptor-neprilysin inhibitors (ARNIs) as de novo therapy, and sodium-glucose cotransporter-2 (SGLT2) inhibitors for heart failure.
•	Updated app structure for improved user experience
•	Updated and expanded Therapy Reference section

• Content edits from the Expert Consensus Decision Pathway on Heart Failure Treatment 11/2018 update
• Updated functionality for patient indicator selections
• Bug fixes